Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TXN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CCT4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BUB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CKAP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPS12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OCIAD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POLR3K - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FARSA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAPDH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ILF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPIE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENSA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SDHC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL36 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGDIA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EXOSC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on